It has been widely established that patients with end‐stage renal disease undergoing
chronic haemodialysis therapy exhibit low endogenous levels of L‐carnitine and elevated …

Though future clinical trials will help establish better-defined guidelines for L-carnitine as a
therapeutic agent, clearly there are subsets of dialysis patients who can benefit from L …

Serum carnitine and serum triglycerides were measured in 45 patients on CAPD and in 14
healthy controls. There was no significant difference between the mean carnitine levels in …

To determine the frequency of low carnitine levels, we measured serum carnitine in pediatric
patients on peritoneal dialysis (PD) and hemodialysis (HD). Our prospective cross-sectional …

Carnitine metabolism and homeostasis is significantly altered in patients receiving
maintenance dialysis. Current literature in the adult and pediatric dialysis populations …

Carnitine is a conditionally essential metabolite that plays a critical role in cell physiology by
participating in transesterification reactions and preventing organic acid accumulation. A …

Aim: L-carnitine is a short organic hydrosoluble molecule and is present in biological
materials like free carnitine and acylcarnitines, which constitute the carnitine system. Long …

Purpose Carnitine deficiency is common in end-stage renal disease (ESRD) patients
receiving hemodialysis (HD) treatment. We investigated the effects of l-carnitine …

Carnitine, a relatively small molecule with 161 Da molecular weight, plays a critical role in
accelerating fatty acid β-oxidation and subsequent energy production within the …

Background Carnitine metabolism in patients on peritoneal dialysis (PD), particularly
automated PD (APD), has not been extensively evaluated. Here, we examined levels of a …